Oncology Nutrition Market Report
RA01948
Oncology Nutrition Market, by Cancer Type (Head and Neck Cancers, Stomach and Gastrointestinal Cancers, Liver Cancer, Pancreatic Cancer, Esophageal Cancer, Lung Cancer, Breast Cancer, Blood Cancer, Other Cancers): Global Opportunity Analysis and Industry Forecast, 2020-2027
The global oncology nutrition market is estimated to surpass $30,932.8 million by 2027, exhibiting a CAGR of 8.7% from 2020 to 2027.
The report provides all-inclusive analysis of global oncology nutrition market with comprehensive study of the various facets of the market including market dynamics, major segments and regions, top leading players, and competitive landscape.
HIGHLIGHTS OF THE REPORT
- This report is a compilation of insights acquired via a detailed study and valid inputs from industry experts & industry participants across the value chain and quantitative & qualitative assessment by analysts of the industry
- The report provides a comprehensive analysis along with the current trends of the market during the forecast period from 2020 to 2027 to identify & comprehend the prevailing opportunities and the strategic assessment of the global oncology nutrition market growth
- The report studies the market from 2019 to 2027 and maps the qualitative impact of several industry factors on market segments as well as geographies
- The report provides market estimations and size which is based on in-depth analysis of recent & key developments in the oncology nutrition market
- The development strategies implemented by the key industry players are conscripted in the report to understand the competitive scenario of the global oncology nutrition market
WHAT DOES THE REPORT OFFER?
The report emphasizes current market scenario and future trends of the global oncology nutrition market which are gleaned from the impact of various market dynamics such as drivers, challenges & restraints, lucrative opportunities. The report also highlights the key forces that are shaping the market.
In addition, the report provides market size and forecast scrutinizing the global oncology nutrition market through different segments. The report highlights the geographical market scenario of each of the segments thoroughly studied at regional as well as country level to get clearer picture of the global oncology nutrition market. In the report, the global oncology nutrition market is divided into four major regions including North America, Europe, Asia-Pacific, and LAMEA. These regions are further divided into major countries to cover the oncology nutrition market landscape in respective regions.
Furthermore, competitive scenario of the global oncology nutrition market is covered in the report. Major players functioning in the global oncology nutrition market are also studied to understand their position and competitive strengths in the industry. The major company profiles covered in the report include various company’s datum such as brief overview, recent financials, main executives, adoption of key growth strategies, novel advancements or initiatives to sustain and expand their position in the global oncology nutrition market, and others.
MAIN SEGMENTS OF THE MARKET
The market has been categorized based on the following segments for the convenience of research:
- Cancer Type: Head and Neck Cancers, Stomach and Gastrointestinal Cancers, Liver Cancer, Pancreatic Cancer, Esophageal Cancer, Lung Cancer, Breast Cancer, Blood Cancer, Other Cancers
Region:
The global oncology nutrition market is divided into North America, Europe, Asia Pacific, and LAMEA.
The above-mentioned regions are further divided in countries as follows:
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Argentina
- Saudi Arabia
- South Africa
- UAE
- Rest of LAMEA
KEY MARKET PLAYERS
The report mentions the major players operating in the global oncology nutrition market that focus on advancements & innovations, partnerships, geographical expansion, and product portfolios to obtain a competitive edge in the market space. The major players enlisted in the report include B.Braun Melsungen AG , Abbott Laboratories, Global Health Products, B.Braun Melsungen AG .
The report summarizes various aspects of all these key players that include as follows:
1. Abbott Laboratories
2. Nestle S.A.
3. Danone
4. Fresenius Kabi AG
5. B.Braun Melsungen AG
6. Mead Johnson Nutrition Company
7. Hormel Foods
8. Meiji Holdings
9. Victus
10. Global Health Products
Research Methodology
Research Dive offers its clients extensive research and analysis gleaned from wide variety of factual inputs that largely includes interview with participants of the industry, reliable data & statistics, and regional intelligence. The in-house experts of the industry play a crucial role in designing analytic tools and models, tailor-made to the requests of an industry segment. The data and statistics are sterilized with these analytical tools and models, which enhances the accuracy of our advice and recommendations.
This research report is delivered by Research Dive by conducting long hours of discussions and interviews, with a broad range of stakeholders, which includes upstream and downstream participants. Our analysts have performed a mix of primary and secondary research for the market estimations and forecasts. A number of product type literatures, industry releases, annual reports, and other related documents of major participants of the industry have been reviewed, to better understand the global oncology nutrition market scenario. The initial phase of our in-depth study, where we perform wide-range data mining, referring to proficient & verified data sources such as independent studies, medical journals, technical journals, releases by trade association, materials published by government & regulatory authorities, and other.
-
1. RESEARCH METHODOLOGY
1.1. Desk Research
1.2. Real time insights and validation
1.3. Forecast model
1.4. Assumptions and forecast parameters
1.5. Market size estimation
1.5.1. Top-down approach
1.5.2. Bottom-up approach
-
2. REPORT SCOPE
2.1. Market definition
2.2. Key objectives of the study
2.3. Report overview
2.4. Market segmentation
2.5. Overview of the impact of COVID-19 on Global Oncology Nutrition Market
-
3. EXECUTIVE SUMMARY
-
4. MARKET OVERVIEW
4.1. Introduction
4.2. Growth impact forces
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Market value chain analysis
4.3.1. List of raw material suppliers
4.3.2. List of manufacturers
4.3.3. List of distributors
4.4. Innovation & sustainability matrices
4.4.1. Technology matrix
4.4.2. Regulatory matrix
4.5. Porter’s five forces analysis
4.5.1. Bargaining power of suppliers
4.5.2. Bargaining power of consumers
4.5.3. Threat of substitutes
4.5.4. Threat of new entrants
4.5.5. Competitive rivalry intensity
4.6. PESTLE analysis
4.6.1. Political
4.6.2. Economical
4.6.3. Social
4.6.4. Technological
4.6.5. Environmental
4.7. Impact of COVID-19 on Oncology Nutrition Market
4.7.1. Pre-covid market scenario
4.7.2. Post-covid market scenario
-
5. Oncology Nutrition Market, By Management
5.1. Overview
5.2 Head and Neck Cancers
5.2.1 Definition, key trends, growth factors, and opportunities
5.2.2 Market size analysis, by region, 2020-2027
5.2.3 Market share analysis, by country, 2020-2027
5.3 Stomach and Gastrointestinal Cancers
5.3.1 Definition, key trends, growth factors, and opportunities
5.3.2 Market size analysis, by region, 2020-2027
5.3.3 Market share analysis, by country, 2020-2027
5.4 Liver Cancer
5.4.1 Definition, key trends, growth factors, and opportunities
5.4.2 Market size analysis, by region, 2020-2027
5.4.3 Market share analysis, by country, 2020-2027
5.5 Pancreatic Cancer
5.5.1 Definition, key trends, growth factors, and opportunities
5.5.2 Market size analysis, by region, 2020-2027
5.5.3 Market share analysis, by country, 2020-2027
5.6 Esophageal Cancer
5.6.1 Definition, key trends, growth factors, and opportunities
5.6.2 Market size analysis, by region, 2020-2027
5.6.3 Market share analysis, by country, 2020-2027
5.7 Lung Cancer
5.7.1 Definition, key trends, growth factors, and opportunities
5.7.2 Market size analysis, by region, 2020-2027
5.7.3 Market share analysis, by country, 2020-2027
5.8 Breast Cancer
5.8.1 Definition, key trends, growth factors, and opportunities
5.8.2 Market size analysis, by region, 2020-2027
5.8.3 Market share analysis, by country, 2020-2027
5.9 Blood Cancer
5.9.1 Definition, key trends, growth factors, and opportunities
5.9.2 Market size analysis, by region, 2020-2027
5.9.3 Market share analysis, by country, 2020-2027
5.10 Other Cancers
5.10.1 Definition, key trends, growth factors, and opportunities
5.10.2 Market size analysis, by region, 2020-2027
5.10.3 Market share analysis, by country, 2020-2027
5.11 Research Dive Exclusive Insights
5.11.1 Market attractiveness
5.11.2 Competition heatmap
6. Oncology Nutrition Market, By Region
6.1 North America
6.1.1 U.S
6.1.1.1 Market size analysis, By Management, 2020-2027
6.1.2 Canada
6.1.2.1 Market size analysis, By Management, 2020-2027
6.1.3 Mexico
6.1.3.1 Market size analysis, By Management, 2020-2027
6.1.4 Research Dive Exclusive Insights
6.1.4.1 Market attractiveness
6.1.4.2 Competition heatmap
6.2 Europe
6.2.1 Germany
6.2.1.1 Market size analysis, By Management, 2020-2027
6.2.2 UK
6.2.2.1 Market size analysis, By Management, 2020-2027
6.2.3 France
6.2.3.1 Market size analysis, By Management, 2020-2027
6.2.4 Spain
6.2.4.1 Market size analysis, By Management, 2020-2027
6.2.5 Italy
6.2.5.1 Market size analysis, By Management, 2020-2027
6.2.6 Rest of Europe
6.2.6.1 Market size analysis, By Management, 2020-2027
6.2.7 Research Dive Exclusive Insights
6.2.7.1 Market attractiveness
6.2.7.2 Competition heatmap
6.3 Asia-Pacific
6.3.1 China
6.3.1.1 Market size analysis, By Management, 2020-2027
6.3.2 Japan
6.3.2.1 Market size analysis, By Management, 2020-2027
6.3.3 India
6.3.3.1 Market size analysis, By Management, 2020-2027
6.3.4 Australia
6.3.4.1 Market size analysis, By Management, 2020-2027
6.3.5 South Korea
6.3.5.1 Market size analysis, By Management, 2020-2027
6.3.6 Rest of Asia-Pacific
6.3.6.1 Market size analysis, By Management, 2020-2027
6.3.7 Research Dive Exclusive Insights
6.3.7.1 Market attractiveness
6.3.7.2 Competition heatmap
6.4 LAMEA
6.4.1 Brazil
6.4.1.1 Market size analysis, By Management, 2020-2027
6.4.2 Saudi Arabia
6.4.2.1 Market size analysis, By Management, 2020-2027
6.4.3 UAE
6.4.3.1 Market size analysis, By Management, 2020-2027
6.4.4 South Africa
6.4.4.1 Market size analysis, By Management, 2020-2027
6.4.5 Rest of LAMEA
6.4.5.1 Market size analysis, By Management, 2020-2027
6.4.6 Research Dive Exclusive Insights
6.4.6.1 Market attractiveness
6.4.6.2 Competition heatmap
7. Competitive Landscape
7.1 Top winning strategies, 2020-2027
7.1.1 By strategy
7.1.2 By year
7.2 Strategic overview
7.3 Market share analysis, 2020-2027
8. Company Profiles
8.1 Abbott Laboratories
8.1.1 Overview
8.1.2 Business segments
8.1.3 Product portfolio
8.1.4 Financial performance
8.1.5 Recent developments
8.1.6 SWOT analysis
8.2 Nestle S.A.
8.2.1 Overview
8.2.2 Business segments
8.2.3 Product portfolio
8.2.4 Financial performance
8.2.5 Recent developments
8.2.6 SWOT analysis
8.3 Danone
8.3.1 Overview
8.3.2 Business segments
8.3.3 Product portfolio
8.3.4 Financial performance
8.3.5 Recent developments
8.3.6 SWOT analysis
8.4 Fresenius Kabi AG
8.4.1 Overview
8.4.2 Business segments
8.4.3 Product portfolio
8.4.4 Financial performance
8.4.5 Recent developments
8.4.6 SWOT analysis
8.5 B.Braun Melsungen AG
8.5.1 Overview
8.5.2 Business segments
8.5.3 Product portfolio
8.5.4 Financial performance
8.5.5 Recent developments
8.5.6 SWOT analysis
8.6 Mead Johnson Nutrition Company
8.6.1 Overview
8.6.2 Business segments
8.6.3 Product portfolio
8.6.4 Financial performance
8.6.5 Recent developments
8.6.6 SWOT analysis
8.7 Hormel Foods
8.7.1 Overview
8.7.2 Business segments
8.7.3 Product portfolio
8.7.4 Financial performance
8.7.5 Recent developments
8.7.6 SWOT analysis
8.8 Meiji Holdings
8.8.1 Overview
8.8.2 Business segments
8.8.3 Product portfolio
8.8.4 Financial performance
8.8.5 Recent developments
8.8.6 SWOT analysis
8.9 Victus
8.9.1 Overview
8.9.2 Business segments
8.9.3 Product portfolio
8.9.4 Financial performance
8.9.5 Recent developments
8.9.6 SWOT analysis
8.10 Global Health Products
8.10.1 Overview
8.10.2 Business segments
8.10.3 Product portfolio
8.10.4 Financial performance
8.10.5 Recent developments
8.10.6 SWOT analysis
Personalize this research
- Triangulate with your own data
- Request your format and definition
- Get a deeper dive on a specific application, geography, customer or competitor
- + 1-888-961-4454 Toll - Free
- support@researchdive.com
